skip to content

Cambridge Academy of Therapeutic Sciences

 

WT Developing Concept Fund

The Wellcome Trust has awarded Cambridge University an INSTITUTIONAL TRANSLATION PARTNERSHIP AWARD (iTPA).

The Developing Concept Fund is intended to pump-prime the translation of novel therapeutics, devices and diagnostics, including repurposing of existing therapies towards a clinical end. 

It is intended that successful project applicants will obtain evidence of the feasibility (or otherwise) of their translational plans, strengthening their chances of obtaining downstream funding. The focus will be on very early stage translational research and projects should be seen as a way to gain sufficient evidence to support follow on funding such as MRC CiC applications. Projects will be encouraged to include a substantive cross-disciplinary collaborative component between basic scientists, clinical scientists and/or industry (as appropraite for the project). Proposals must be led by a Principal Investigator at the University of Cambridge.

The fund supports projects up to a maximum of £50,000 each for 9 months..

 

This call is now OPEN and the deadline for applications is Monday 31st August 2020

​Please email Cathy Boucher if you have any queries regarding your application.

 

Panel

The expert panel includes:
Dr John Skidmore (Chair), Chief Scientific Officer ALBORADA Drug Discovery Institute
Prof Margaret Ashcroft, Department of Medicine
Prof Michael Sutcliffe, Theme Leader of Bioengineering
Dr Dave Smith, Principal Scientist, AstraZeneca
Mr Stuart Kay, Director Medtech Solutions Ltd
Prof David Jayne, Director of the Vasculitis and Lupus Service, Addenbrooke’s Hospital
Dr Tim Allsopp, Industry Expert in Residence at the University of Cambridge
Dr John Pritchard, Industry Expert in Residence at the University of Cambridge
Dr Terry Parlett, Commercialisation Director, Cambridge Enterprise
Dr Neil Thompson, Independent Consultant